$55.00Original price was: $55.00.$50.40Current price is: $50.40.
GHRP-6 is a synthetic ghrelin/growth hormone secretagogue agonist. It has positive effects on appetite, heart muscle cells, scar formation, and sexual motivation. Animal studies show this orally active growth hormone secretagogue also improves memory function and may help to thwart the neurological effects of Parkinson’s disease.
GHRP-6 is typically administered subcutaneously once or multiple times per day, depending on individual goals such as growth hormone (GH) stimulation, appetite regulation, recovery, or body recomposition. A standard starting dose is 100 mcg (0.05 ml) once daily. For enhanced effects, the dose can be increased to 200–300 mcg (0.1–0.15 ml), administered two to three times daily.
A common escalation schedule may look like this:
Week 1–2: 100 mcg (0.05 ml) once daily, preferably at night
Week 3–4: Increase to 100–200 mcg (0.05–0.1 ml) twice daily
Week 5 onward: 200–300 mcg (0.1–0.15 ml) up to three times per day, ideally pre-meal and before sleep
Injections should be administered subcutaneously into abdominal or thigh fat, with rotation of sites to reduce irritation. GHRP-6 is best taken on an empty stomach, as carbohydrates and fats can blunt the GH release effect.
Each 10ml vial provides 20 mg of GHRP-6, allowing for:
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates the release of growth hormone via ghrelin receptor activation. It belongs to the GHRP family and acts primarily on the GHSR-1a receptor in the pituitary and hypothalamus.
What sets GHRP-6 apart is its strong ability to stimulate appetite while promoting endogenous GH release, making it highly useful for muscle building, tissue repair, and metabolic recovery in individuals with low appetite or high caloric needs.
GHRP-6 is also frequently used in combination with GHRH analogs (e.g., CJC-1295) for synergistic effects.
GHRP-6 binds to the ghrelin receptor (GHSR-1a), directly stimulating the anterior pituitary to release growth hormone. Unlike GHRH analogs, GHRPs bypass the hypothalamic regulation pathway, which leads to a potent and rapid GH surge after administration.
Additional actions include:
Stimulation of appetite via central ghrelin pathways
Promotion of IGF-1 production via GH stimulation
Enhanced recovery and protein synthesis
Immune modulation and cellular regeneration
When combined with GHRH analogs like CJC-1295, the effects are amplified, leading to increased pulse amplitude and duration of GH secretion.
GHRP-6 is not recommended during pregnancy or breastfeeding due to its endocrine activity and lack of safety data in human reproductive models. Animal data are limited and inconclusive.
GHRP-6 is not FDA-approved for use in children. Though it stimulates GH, it should only be used in pediatric populations under strict medical supervision for legitimate endocrine deficiencies.
GHRP-6 is not FDA-approved for medical use and is classified as an investigational peptide. It is widely used in clinical research and functional medicine contexts for its ability to stimulate growth hormone release and appetite.
